Showing 1 posts of 1 posts found.
Pfizer has confirmed the FDA approval of Abrilada (adalimumab-afzb), its biosimilar version of AbbVie’s Humira, the world’s best-selling drug, …
AbbVie expands Oxford R&D facility with new £120m UK research commitment
MedPharm appoints Jason Mieding as chief operating officer
UKRI backs five hubs developing AI tools for earlier disease detection
Coriolis Pharma appoints Teun van der Heide as CEO
NEC joins €6.5m European project using AI for pandemic vaccine design